Viewing Study NCT00979251


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2026-02-24 @ 5:51 AM
Study NCT ID: NCT00979251
Status: COMPLETED
Last Update Posted: 2014-04-14
First Post: 2009-09-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects
Sponsor: Adamas Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Influenza View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Influenza View
None Immunocompromised View
None HIV View
None History of transplant View